重症肿瘤患者限制性与开放性输血策略对比:重症肿瘤患者输血需求随机对照试验
该单中心、随机、双盲对照试验纳入ICU入住6小时内的成人肿瘤合并感染性休克患者,随机分为开放性输血组(血红蛋白阈值<9 g/dL,n=149)与限制性输血组(<7 g/dL,n=151)。开放性组接受的RBC单位数多于限制性组(1[0-3] vs 0[0-2]单位,p<0.001)。28天死亡率主要终点:开放性组45%(67例)vs 限制性组56%(84例),HR 0.74(95%CI 0.53-1.04),p=0.08,未达统计学显著;ICU及住院时间无差异。90天死亡率开放性组较低(59% vs 70%),HR 0.72(95%CI 0.53-0.97),p=0.03。作者观察到生存趋势 favoring 开放性输血策略,与先验假设及其他试验方向相反,需进一步确认。
要点
- 在感染性休克成人肿瘤患者中,开放性输血(Hb<9 g/dL)较限制性(Hb<7 g/dL)28天死亡率无统计学显著差异:45%(67例)vs 56%(84例),HR 0.74(95%CI 0.53-1.04),p=0.08。
- 90天死亡率开放性组低于限制性组:59% vs 70%,HR 0.72(95%CI 0.53-0.97),p=0.03。
- 开放性组接受的RBC单位数多于限制性组:1[0-3] vs 0[0-2]单位,p<0.001。
- 两组ICU及住院时间无差异。
- 作者结论:观察到 favoring 开放性输血策略的生存趋势,与先验假设及其他试验方向相反,需进一步确认。
适用人群与场景
- 成人肿瘤患者,感染性休克,ICU入住后6小时内纳入。
诊断标准与关键阈值
- 开放性输血策略:血红蛋白阈值<9 g/dL时输注RBC。
- 限制性输血策略:血红蛋白阈值<7 g/dL时输注RBC。
处置流程与药物剂量
- 开放性策略组:ICU期间血红蛋白<9 g/dL时输注RBC。
- 限制性策略组:ICU期间血红蛋白<7 g/dL时输注RBC。
研究设计与关键结果
- 单中心、随机、双盲对照试验,纳入成人肿瘤合并感染性休克患者,开放性组n=149,限制性组n=151。
- 开放性组接受的RBC单位数多于限制性组:1[0-3] vs 0[0-2]单位,p<0.001。
- 28天死亡率(主要终点):开放性组45%(67例)vs 限制性组56%(84例),HR 0.74(95%CI 0.53-1.04),p=0.08。
- 90天死亡率:开放性组59% vs 限制性组70%,HR 0.72(95%CI 0.53-0.97),p=0.03。
- ICU及住院时间两组无差异。
证据类型、等级与局限
- 证据类型:单中心、随机、双盲对照试验。
- 局限:作者结论指出结果与先验假设及其他试验方向相反,需进一步确认。
对床旁实践的改变
- 作者观察到在感染性休克成人肿瘤患者中,开放性输血策略(Hb<9 g/dL)较限制性策略(Hb<7 g/dL)有生存趋势获益,但28天主要终点未达统计学显著,90天死亡率降低,需进一步确认。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To assess whether a restrictive strategy of RBC transfusion reduces 28-day mortality when compared with a liberal strategy in cancer patients with septic shock.
DESIGN: Single center, randomized, double-blind controlled trial.
SETTING: Teaching hospital.
PATIENTS: Adult cancer patients with septic shock in the first 6 hours of ICU admission.
INTERVENTIONS: Patients were randomized to the liberal (hemoglobin threshold, < 9 g/dL) or to the restrictive strategy (hemoglobin threshold, < 7 g/dL) of RBC transfusion during ICU stay.
MEASUREMENTS AND MAIN RESULTS: Patients were randomized to the liberal (n = 149) or to the restrictive transfusion strategy (n = 151) group. Patients in the liberal group received more RBC units than patients in the restrictive group (1 [0-3] vs 0 [0-2] unit; p < 0.001). At 28 days after randomization, mortality rate in the liberal group (primary endpoint of the study) was 45% (67 patients) versus 56% (84 patients) in the restrictive group (hazard ratio, 0.74; 95% CI, 0.53-1.04; p = 0.08) with no differences in ICU and hospital length of stay. At 90 days after randomization, mortality rate in the liberal group was lower (59% vs 70%) than in the restrictive group (hazard ratio, 0.72; 95% CI, 0.53-0.97; p = 0.03).
CONCLUSIONS: We observed a survival trend favoring a liberal transfusion strategy in patients with septic shock when compared with the restrictive strategy. These results went in the opposite direction of the a priori hypothesis and of other trials in the field and need to be confirmed.
参考来源
- Bergamin FS, Almeida JP, Landoni G, et al. Liberal Versus Restrictive Transfusion Strategy in Critically Ill Oncologic Patients: The Transfusion Requirements in Critically Ill Oncologic Patients Randomized Controlled Trial. Crit Care Med. 2017. PMID: 28240687. doi:10.1097/CCM.0000000000002283
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。